These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 5158408)

  • 1. (Ureyl- 14 C) tolbutamide and (2- 14 C) pentobarbitone as substrates for the hepatic microsomal drug-metabolizing enzyme system in vitro.
    Darby FJ; Evans DA
    J Physiol; 1971 Dec; 219(2):7P-8P. PubMed ID: 5158408
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition by ethylmorphine and pentobarbitone in vitro of the metabolism of (ureyl- 14 C)tolbutamide by hepatic microsomal preparations from male and female rats treated with phenobarbitone.
    Darby FJ
    Biochem Pharmacol; 1972 Jun; 21(11):1649-56. PubMed ID: 4646789
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition by ethylmorphine and pentobarbitone in vitro of the metabolism of (ureyl- 14 C)tolbutamide by hepatic microsomal preparations from sexually-immature male and female rats treated with phenobarbitone.
    Darby J
    Biochem Pharmacol; 1973 Apr; 22(8):989-92. PubMed ID: 4693832
    [No Abstract]   [Full Text] [Related]  

  • 4. The metabolism in vitro of (ureyl-14C)-tolbutamide by microsomal preparations from rat and human liver.
    Darby FJ; Evans DA
    Biochem J; 1971 Nov; 125(2):46P-47P. PubMed ID: 5144753
    [No Abstract]   [Full Text] [Related]  

  • 5. Apparent Michaelis constants for the metabolism of (ureyl- 14 C)tolbutamide by human liver microsomal preparations.
    Darby FJ; Grundy RK; Evans DA
    Biochem Pharmacol; 1972 Feb; 21(3):407-14. PubMed ID: 5014495
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of acute and repeated chlordimeform treatment on rat hepatic microsomal drug metabolizing enzymes.
    Budris DM; Yim GK; Schnell RC
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):175-82. PubMed ID: 6440975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nickel carbonyl upon incorporation of 14 C-leucine into hepatic microsomal proteins.
    Sunderman FW
    Res Commun Chem Pathol Pharmacol; 1970 Mar; 1(2):161-8. PubMed ID: 5524318
    [No Abstract]   [Full Text] [Related]  

  • 8. Stimulation of tolbutamide hydroxylation by acetone and acetonitrile in human liver microsomes and in a cytochrome P-450 2C9-reconstituted system.
    Palamanda J; Feng WW; Lin CC; Nomeir AA
    Drug Metab Dispos; 2000 Jan; 28(1):38-43. PubMed ID: 10611138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginkgo biloba extract modifies hypoglycemic action of tolbutamide via hepatic cytochrome P450 mediated mechanism in aged rats.
    Sugiyama T; Kubota Y; Shinozuka K; Yamada S; Wu J; Umegaki K
    Life Sci; 2004 Jul; 75(9):1113-22. PubMed ID: 15207658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of pargyline with tolbutamide in rabbits.
    Satyanarayana S; Krishna DM; Krishnaiah YS; Visweswaram D
    Indian J Physiol Pharmacol; 1995 Jan; 39(1):71-3. PubMed ID: 7705875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolism of (ureyl-14C)tolbutamide in vitro and in vivo in man.
    Darby FJ; Grundy RK
    Life Sci; 1973 Jul; 13(2):97-105. PubMed ID: 4356419
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of benzodiazepines on enzymes metabolizing drugs. IV. Effect of diazepam and oxazepam on hepatic microsomal drug metabolizing enzymes in rats exposed to high environmental temperature.
    Pachecka J; Kobylińska K; Zagdańska B; Zasłona H; Bicz W
    Acta Pol Pharm; 1990; 47(1-2):23-6. PubMed ID: 12959254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of liver congestion on hepatic drug metabolism in the rat.
    Knodell RG; Farleigh RM; Steele NM; Bond JH
    J Pharmacol Exp Ther; 1982 Apr; 221(1):52-7. PubMed ID: 7062291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic analysis of tolbutamide-sulfonamide interaction in rabbits based on clearance concept. Prediction of species difference from in vitro plasma protein binding and metabolism.
    Sugita O; Sawada Y; Sugiyama Y; Iga T; Hanano M
    Drug Metab Dispos; 1984; 12(1):131-8. PubMed ID: 6141904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic factors influencing the metabolism of tolbutamide.
    Back DJ; Orme ML
    Pharmacol Ther; 1989; 44(2):147-55. PubMed ID: 2519343
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug kinetics and alcohol ingestion.
    Sellers EM; Holloway MR
    Clin Pharmacokinet; 1978; 3(6):440-52. PubMed ID: 31257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of 3,4-dichlorophenyl methyl sulfone, a metabolite of o-dichlorobenzene, in the changes in hepatic microsomal drug-metabolizing enzymes caused by o-dichlorobenzene administration in rats.
    Kato Y; Kimura R
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):277-84. PubMed ID: 9266800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ethinyl estradiol on pharmacokinetics of meperidine and pentobarbital in the rat.
    Knodell RG; Allen RC; Kyner WT
    J Pharmacol Exp Ther; 1982 Apr; 221(1):1-6. PubMed ID: 7062276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a New Dynamic Model to Predict the In Vitro Intrinsic Clearance of Tolbutamide Using Rat Microsomes Encapsulated in a Fab Hydrogel.
    Zhou N; Zheng Y; Xing J; Yang H; Chen H; Xiang X; Liu J; Tong S; Zhu B; Cai W
    Drug Metab Dispos; 2016 Jan; 44(1):40-9. PubMed ID: 26467766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinine and quinidine inhibition of pentobarbital metabolism.
    Boulos BM; Short CR; Davis LE
    Biochem Pharmacol; 1970 Mar; 19(3):723-32. PubMed ID: 5507679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.